Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 495

1.
2.
3.

Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.

Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C.

Eur Urol. 2011 Oct;60(4):742-50. doi: 10.1016/j.eururo.2011.07.002. Epub 2011 Jul 13.

PMID:
21798658
4.

Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.

Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF; Botox Detrusor Hyperreflexia Study Team.

J Urol. 2005 Jul;174(1):196-200.

PMID:
15947626
5.

Botulinum toxin for the management of bladder dysfunction.

Schurch B.

Drugs. 2006;66(10):1301-18. Review.

PMID:
16903766
6.

Botulinum toxin treatment for bladder dysfunction.

Santos-Silva A, da Silva CM, Cruz F.

Int J Urol. 2013 Oct;20(10):956-62. doi: 10.1111/iju.12188. Epub 2013 May 2. Review.

7.

Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.

Ginsberg D, Gousse A, Keppenne V, Sievert KD, Thompson C, Lam W, Brin MF, Jenkins B, Haag-Molkenteller C.

J Urol. 2012 Jun;187(6):2131-9. doi: 10.1016/j.juro.2012.01.125. Epub 2012 Apr 12.

PMID:
22503020
8.

European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.

Reitz A, Stöhrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, Burgdörfer H, Göcking K, Madersbacher H, Schumacher S, Richter R, von Tobel J, Schurch B.

Eur Urol. 2004 Apr;45(4):510-5.

PMID:
15041117
9.

Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.

Chen G, Liao L.

Int Urol Nephrol. 2011 Sep;43(3):655-62. doi: 10.1007/s11255-010-9873-x. Epub 2010 Nov 26.

PMID:
21110094
10.

Botulinum toxin injections for adults with overactive bladder syndrome.

Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD005493. doi: 10.1002/14651858.CD005493.pub3. Review.

PMID:
22161392
11.

Botulinum toxin injections for adults with overactive bladder syndrome.

Duthie J, Wilson DI, Herbison GP, Wilson D.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005493. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD005493.

PMID:
17636801
12.

Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.

Smith CP, Nishiguchi J, O'Leary M, Yoshimura N, Chancellor MB.

Urology. 2005 Jan;65(1):37-41.

PMID:
15667859
13.

Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.

Utomo E, Groen J, Blok BF.

Cochrane Database Syst Rev. 2014 May 24;(5):CD004927. doi: 10.1002/14651858.CD004927.pub4. Review.

PMID:
24859260
14.
15.

Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.

Gamé X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudié I, De Boissezon X, Malavaud B, Marque P, Rischmann P.

Eur Urol. 2008 Mar;53(3):613-8. Epub 2007 Aug 28.

PMID:
17804150
16.

Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.

Herschorn S, Gajewski J, Ethans K, Corcos J, Carlson K, Bailly G, Bard R, Valiquette L, Baverstock R, Carr L, Radomski S.

J Urol. 2011 Jun;185(6):2229-35. doi: 10.1016/j.juro.2011.02.004. Epub 2011 Apr 16.

PMID:
21497851
17.

Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.

Alvares RA, Silva JA, Barboza AL, Monteiro RT.

Int Braz J Urol. 2010 Nov-Dec;36(6):732-7.

18.
19.

Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.

Karsenty G, Reitz A, Lindemann G, Boy S, Schurch B.

Urology. 2006 Dec;68(6):1193-7. Epub 2006 Dec 4.

PMID:
17141831
20.

Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study.

Krhut J, Samal V, Nemec D, Zvara P.

Spinal Cord. 2012 Dec;50(12):904-7. doi: 10.1038/sc.2012.76. Epub 2012 Jul 17.

PMID:
22801191

Supplemental Content

Support Center